Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Choline-dependent methionine metabolism supports leukemia progression.

Communications biology·2026
Same author

Corrigendum to STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice.

The Journal of clinical investigation·2025
Same author

Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress.

Blood·2023
Same author

The YEATS domain epigenetic reader proteins ENL and AF9 and their therapeutic value in leukemia.

Experimental hematology·2023
Same author

Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress.

bioRxiv : the preprint server for biology·2023
Same author

The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia.

Leukemia·2022

Related Experiment Video

Updated: May 28, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

The pathogenesis of mixed-lineage leukemia.

Andrew G Muntean1, Jay L Hess

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA. andrewmu@umich.edu

Annual Review of Pathology
|October 25, 2011
PubMed
Summary

Rearrangements in the mixed-lineage leukemia gene (MLL) drive aggressive leukemias in children and adults. Understanding these MLL gene alterations is crucial for developing novel therapeutic strategies against these challenging hematopoietic malignancies.

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Related Experiment Videos

Last Updated: May 28, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Aggressive leukemias in children and adults are frequently caused by alterations to the mixed-lineage leukemia (MLL) gene on chromosome 11q23.
  • The MLL gene encodes a histone methyltransferase critical for regulating gene transcription, including homeobox (HOX) genes.

Purpose of the Study:

  • To review the molecular mechanisms underlying MLL-associated leukemias.
  • To discuss the etiology of these aggressive hematopoietic malignancies.
  • To explore potential future therapeutic avenues.

Main Methods:

  • Review of current literature on MLL gene alterations and associated leukemias.
  • Analysis of molecular mechanisms driving MLL leukemogenesis.
  • Discussion of therapeutic strategies and future directions.

Main Results:

  • MLL gene alterations, including translocations, duplications, and amplifications, lead to sustained HOX gene expression and impaired cell differentiation.
  • These genetic lesions are implicated in both acute myeloid leukemia and acute lymphoid leukemia.
  • MLL-associated leukemias often present with a poor prognosis, even with advanced treatments like stem cell transplantation.

Conclusions:

  • Recent research has elucidated key molecular pathways in MLL leukemias, opening doors for targeted therapies.
  • Further investigation into MLL gene function and dysregulation is essential for improving treatment outcomes.
  • Developing novel therapeutic regimens is a critical unmet need for patients with MLL-associated leukemias.